Business Context and Reporting Period
Company: Creative Medical Technology Holdings, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 7, 2017
Reporting Period: Single event date (June 7, 2017)
The filing reports a corporate event under Item 8.01 (Other Events) regarding the announcement of a new technology platform.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a strategic development announcement rather than financial performance data.
Material Changes
Strategic Development: On June 7, 2017, the Company issued a press release announcing the development of a platform aimed at augmenting all mesenchymal stem cell therapies for lower back pain.
Guidance, Outlook, and Risks
- Forward-Looking Statements: The press release (Exhibit 99.1) contains forward-looking statements based on information available as of June 7, 2017.
- Risk Factors: Actual results could differ materially from anticipated results due to various factors discussed in the Company's Annual Report on Form 10-K for the year ended December 31, 2016, and subsequent SEC filings.
- Management Commentary: The Company assumes no duty or obligation to update or revise forward-looking statements, though it may do so via future reports or press releases.
Investor Verification Checklist
- Review the full text of the press release (Exhibit 99.1) for specific details on the stem cell therapy platform.
- Examine the Form 10-K for the year ended December 31, 2016, to understand the risk factors referenced in this filing.
- Verify the Company's current financial status through subsequent filings, as this 8-K contains no financial data.